Please login to the form below

Not currently logged in


This page shows the latest risankizumab news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s Crohn’s disease drug given green light by MHRA

AbbVie’s Crohn’s disease drug given green light by MHRA

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a positive opinion under the Early Access to Medicines Scheme (EAMS) for AbbVie’s risankizumab. ... Having risankizumab available via the early access scheme is a positive

Latest news

More from news
Approximately 4 fully matching, plus 28 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Box 1
Strategic commitment
KOL Ambassador Program & Podcast Creation: A Customer Story
Animation: Living With
The journey from the patient's perspective...